Sleepin Dogo2d ago
Tesla publishes 1Q 2026 deliveries estimate of 365,645, vs Q4 2025 418,227... ir.tesla.com/press-releas... #$TSLA #$TSLAQ

x.com/zerohedge/stat...
G-Prophet4d ago
📈 $TSLA BULLISH signal — G-Prophet AI confidence: 78%. Free AI stock analysis at gprophet.com #StockMarket #AITrading #TSLA
G-Prophet4d ago
📈 $TSLA BULLISH signal — G-Prophet AI confidence: 78%. Free AI stock analysis at gprophet.com #StockMarket #AITrading #TSLA
G-Prophet4d ago
📈 $TSLA BULLISH signal — G-Prophet AI confidence: 78%. Free AI stock analysis at gprophet.com #StockMarket #AITrading #TSLA
G-Prophet5d ago
📈 $TSLA BULLISH signal — G-Prophet AI confidence: 78%. Free AI stock analysis at gprophet.com #StockMarket #AITrading #TSLA
G-Prophet5d ago
📈 $TSLA BULLISH signal — G-Prophet AI confidence: 78%. Free AI stock analysis at gprophet.com #StockMarket #AITrading #TSLA
G-Prophet5d ago
📈 $TSLA BULLISH signal — G-Prophet AI confidence: 78%. Free AI stock analysis at gprophet.com #StockMarket #AITrading #TSLA
Sascha WyciskMar 20

Wie man altbekanntes immer wieder als neu Verkaufen kann.
#tesla #musk #tsla #fsd #gefahr #nhsta

Autopilot-Risiko: Tesla-Aktie: US-Behörde untersucht FSD wegen möglicher Sicherheitsprobleme

https://www.finanzen.net/nachricht/aktien/autopilot-risiko-tesla-aktie-us-behoerde-untersucht-fsd-wegen-moeglicher-sichtprobleme-15567092

NASDAQ-Titel Tesla-Aktie: US-Behörde sieht Risiken bei FSD-System

Die US-Verkehrssicherheitsbehörde vertieft ihre Untersuchung von Teslas Computersystem, das Elektroautos des Konzerns durch den Verkehr steuern soll.

finanzen.net
AstroconomicsMar 18
Explain Wednesday | TSLA
Data: Price $399.27; NeuroScore 0.35/1.00; Street tgt +5.6%
Thesis: Price $399.27; NeuroScore 0.35/1.00; 1M -4.3%
Risk: earnings in 35d; guide and margin trend vs consensus.
NeuroScore runs 0-1 (higher = stronger composite setup, 30d view).
#TSLA #Research
ElectrekMar 17

Tesla (TSLA) Terafab plans point to inevitable capital raise — its first since 2020

https://fed.brid.gy/r/https://electrek.co/2026/03/17/tesla-tsla-terafab-capital-raise-secondary-offering/